Expression of erbB-1 and erbB-2 genes in normal and pathological human endometrium

Oncology Reports

Volumn 18, Issue 1, 2007, Pages 261-265

  Brys, Magdalena ^a   Semczuk, Andrzej ^b   Rechberger, Tomasz ^b   Krajewska, Wanda M ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Endometrial cancer; erbB 1; erbB 2; RT PCR

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; TUMOR MARKER;

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; AGED; ARTICLE; COMPARATIVE STUDY; ENDOMETRIUM; ENDOMETRIUM TUMOR; FEMALE; GENETICS; HUMAN; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA, CLEAR CELL; AGED; AGED, 80 AND OVER; CARCINOMA, ADENOSQUAMOUS; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 34548047716     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.18.1.261     Document Type: Article

References (42)

1. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote I: Endometrial cancer. Lancet 366: 491-505, 2005. (Pubitemid 41111699)
2. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ and American Cancer Society: Cancer Statistics, 2004. CA Cancer J Clin 54: 8-29, 2004.
3. Wojciechowska U, Didkowska J, Tarkowski W and Zatonski W: Cancer in Poland in 2002. The Maria Sklodowska-Curie Memorial Cancer Center, National Cancer Registry, Warsaw, Poland, 2004.
4. Hacker NF: Uterine cancer. In: Practical Gynecologic Oncology. Berek JS and Hacker NF (eds). Lippincott Williams and Wilkins, Philadephia, pp397-442, 2005.
5. Sandles LG, Shulman LP, Elias S, Photopulos GJ, Smiley LM, Posten WM and Simpson JL: Endometrial adenocarcinoma: genetic analysis suggesting heritable site-specific uterine cancer. Gynecol Oncol 47: 167-171, 1992. (Pubitemid 23001323)
6. Hom YK, Young P, Wiesen JF, Miettinen PJ, Derynck R, Werb Z and Cunha GR: Uterine and vaginal organ growth requires epidermal growth factor receptor signaling from stroma. Endocrinology 139: 913-921, 1998. (Pubitemid 28510105)
7. Rasty G, Murray R, Lu L, Kubilis P, Benrubi G and Masood S: Expression of HER-2/neu oncogene in normal, hyperplastic, and malignant endometrium. Ann Clin Lab Sci 28: 138-143, 1998. (Pubitemid 28265540)
8. Pearl ML, Talavera F, Gretz HF III, Roberts JA and Menon KM: Mitogenic activity of growth factors in the human endometrial adenocarcinoma cell lines HEC-1-A and KLE. Gynecol Oncol 49: 325-332, 1993. (Pubitemid 23191205)
9. Lelle RJ, Talavera F, Gretz H, Roberts JA and Menon KM: Epidermal growth factor receptor expression in three different human endometrial cancer cell lines. Cancer 72: 519-525, 1993. (Pubitemid 23193461)
10. Connor P, Talavera F, Kang JS, Burke J, Roberts J and Menon KM: Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A. Gynecol Oncol 67: 46-50, 1997. (Pubitemid 27433327)
11. Gretz HF III, Talavera F, Connor P, Pearl M, Lelle RJ, Roberts JA and Menon KM: Protein kinase C-dependent and -independent pathways mediate epidermal growth factor (EGF) effects in human endometrial adenocarcinoma cell line KLE. Gynecol Oncol 53: 228-233, 1994. (Pubitemid 24177049)
12. Gullick WJ, Marsden JJ, Whittle N, Ward B, Bobrow L and Waterfield MD: Expression of epidermal growth factor receptors on human cervical, ovarian and vulvar carcinomas. Cancer Res 46: 285-292, 1986. (Pubitemid 16189064)
13. Bauknecht T, Kohler M, Janz I and Pfeiderer A: The occurrence of epidermal growth factor receptors and the characterisation of EGF-like factors in human ovarian, endometrial, cervical and breast cancer. EGF receptors and factors in gynecological carcinomas. J Cancer Res Clin Oncol 115: 193-199, 1989. (Pubitemid 19109380)
14. Berchuck A, Rodriguez G, Kamel A, Soper JT, Clarke-Pearson DL and Bast RC Jr: Expression of epidermal growth factor receptor and HER-2/neu in normal and neoplastic cervix, vulva, and vagina. Obstet Gynecol 76: 381-387, 1990. (Pubitemid 20264521)
15. Pfeiffer D, Spranger J, Al-Deiri M, Kimmig R, Fisseler-Eckhoff A, Scheidel P, Schatz H, Jensen A and Pfeiffer A: mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus. Int J Cancer 72: 581-586, 1997. (Pubitemid 27356156)
16. Miturski R, Semczuk A, Postawski K and Jakowicki JA: Epidermal growth factor receptor immunostaining and epidermal growth factor receptor-tyrosine kinase activity in proliferative and neoplastic human endometrium. Tumor Biol 21: 358-366, 2000.
17. Hetzel DJ, Wilson TO, Keeney GL, Roche PC, Cha SS and Podratz KC: HER-2/neu expression: a major prognostic factor in endometrial cancer. Gynecol Oncol 47: 179-185, 1992. (Pubitemid 23001325)
18. Kohlberger P, Loesch A, Koelbl H, Breitenecker G, Kainz CH and Gitsch G: Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer. Cancer Lett 98: 151-155, 1996. (Pubitemid 26010324)
19. Santin AD, Bellone S, Gokden M, Palmieri M, Dunn D, Agha J, Roman JJ, Hutchins L, Pecorelli S, O'Brien T, Cannon MJ and Parham GP: Overexpression of HER-2/neu in uterine serous papillary cancer. Clin Cancer Res 8: 1271-1279, 2002. (Pubitemid 34517668)
20. Mikuta JJ: Preoperative evaluation and staging of endometrial cancer. Cancer 76 (suppl 10): 2041-2043, 1995.
21. Tavassoli FA and Devilee P: Pathology and genetics of tumours of the breast and female genital organs. International Agency for Research on Cancer (IARC), IARC Press, Lyon, 2003.
22. Chomczynski P and Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987. (Pubitemid 17064313)
23. Thøgersen VB, Bross P, Gregersen N and Nexo E: Quantitative analysis of the human epidermal growth factor receptor messenger RNA using reverse transcription-PCR: a methodological study of imprecision. Clin Chem 44: 1344-1346, 1998. (Pubitemid 28283079)
24. Piestrzeniewicz-Ulanska D, Brys M, Semczuk A, Jakowicki JA and Krajewska WM: Expression and intracellular localization of Smad proteins in human endometrial cancer. Oncol Rep 10: 1539-1544, 2003.
25. Graus-Porta D, Beerli RR, Daly JM and Hyner NE: ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16: 1647-1655, 1997. (Pubitemid 27151960)
26. Scaltriti M and Baselga J: The epidermal growth factor receptor pathway: A model for targeted therapy. Clin Cancer Res 12: 5268-2572, 2006.
27. Brumm C, Riviere A, Wilckens C and Loning T: Immunohistochemical investigation and Northern blot analysis of c-erB-2 expression in normal, premalignant and malignant tissues of the corpus and cervix uteri. Virchows Arch A Pathol Anat Histopathol 417: 477-484, 1990.
28. Nyholm HC, Nielsen AL and Ottesen B: Expression of epidermal growth factor receptors in human endometrial carcinoma. Int J Gynecol Pathol 12: 241-245, 1993. (Pubitemid 23182239)
29. Jasonni VM, Amadori A, Santini D, Ceccarelli C, Naldi S and Flamigni C: Epidermal growth factor receptor (EGF-R) and transforming growth factor alpha (TGFa) expression in different endometrial cancers. Anticancer Res 15: 1327-1332, 1995.
30. Reinartz JJ, George E, Lindgren BR and Niehans GA: Expression of p53, transforming growth factor alpha, epidermal growth factor receptor, and c-erbB-2 in endometrial carcinoma and correlation with survival and known predictors of survival. Hum Pathol 25: 1075-1083, 1994. (Pubitemid 24313653)
31. Niikura H, Sasano H, Matsunaga G, Watanabe K, Ito K, Sato S and Yajima A: Prognostic value of epidermal growth factor receptor expression in endometrioid endometrial carcinoma. Hum Pathol 26: 892-896, 1995.
32. Khalifa MA, Mannel RS, Haraway SD, Walker J and Min K-W: Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gynecol Oncol 53: 84-92, 1994. (Pubitemid 24136907)
33. Nazeer T, Ballouk F, Malfetano JH, Figge H and Ambros RA: Multivariate survival analysis of clinicopathologic features in surgical stage I endometrioid carcinoma including analysis of HER-2/neu expression. Am J Obstet Gynecol 173: 1829-1834, 1995. (Pubitemid 26005771)
34. Coronado PJ, Vidart JA, Lopez-Asenjo JA, Fasero M, Furio-Bacete V, Magrina J and Escudero M: P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression. Eur J Obstet Gynecol Reprod Biol 98: 103-108, 2001. (Pubitemid 32758843)
35. Pisani AL, Barbuto DA, Chen D, Ramos L, Lagasse LD and Karlan BY: HER-2/neu, p53 and DNA analyses as prognosticators for survival in endometrial carcinoma. Obstet Gynecol 85: 729-734, 1995.
36. Backe J, Gassel AM, Krebs S, Muller T and Caffier H: Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma. Arch Gynecol Obstet 259: 189-195, 1997. (Pubitemid 27379677)
37. Kokai Y, Myers JN, Wada T, Brown VI, LeVea CM, Davis JG, Dobashi K and Green MI: Synergistic interaction of p185c-neu and the EGF receptor leads to transformation of rodent fibroblasts. Cell 58: 287-292, 1989. (Pubitemid 19191411)
38. Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ and Yarden Y: A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation/neuregulin and epidermal growth factor. Mol Cell Biol 16: 5276-5287, 1996. (Pubitemid 26315047)
39. Semczuk A, Baranowski W, Berbec H, Marzec B, Skomra D and Miturski R: Analysis of p53 and K-ras genes and their proteins in a sarcoma botryoides of the uterine cervix. Eur J Gynaecol Oncol 20: 311-314, 1999. (Pubitemid 30113735)
40. Hynes NE and Lane HA: ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354, 2005. (Pubitemid 40637826)
41. Santin AD: HER2/neu overexpression: Has the Achilles' heel of uterine serous papillary carcinoma been exposed? Gynecol Oncol 88: 263-265, 2003.
42. Livasy CA, Reading FC, Moore DT, Boggess JF and Lininger RA: EGFR expression and HER2/neu overexpression/ amplification in endometrial carcinosarcoma. Gynecol Oncol 100: 101-106, 2006. (Pubitemid 41815057)